Entrepreneurs in the biotech industry require large risk thresholds. For one, the business of research is an expensive one, the results of which may not necessarily translate to commercial viability. Investors with the foresight and patience for such long-term, high-risk ventures are also hard to come by. At a talk organised by SMU's Lee Kong Chian School of Business, Dr. Steven Fang, founder of CordLife, shared insights on what 'biotechopreneurship' entails.
Business | Entrepreneurial and Small Business Operations | Technology and Innovation
Copyright Owner and Holder
Copyright © Singapore Management University 2012
Innovation and Entrepreneurship
Risky ventures with possibly no returns: the allure of the "wonderful but weird world of biotechnology". (2011). Knowledge@SMU.
Available at: http://ink.library.smu.edu.sg/ksmu/173